178 related articles for article (PubMed ID: 32434081)
1. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
[TBL] [Abstract][Full Text] [Related]
2. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
3. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).
Wojakowski W; Pyrlik A; Król M; Buszman P; Ochała A; Milewski K; Smolka G; Kawecki D; Rudnik A; Pawłowski T; Jadczyk T; Wyderka R; Cybulski W; Dworowy S; Tendera M
Minerva Cardioangiol; 2013 Jun; 61(3):301-11. PubMed ID: 23681133
[TBL] [Abstract][Full Text] [Related]
5. Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model.
Huang YH; Xu Q; Shen T; Li JK; Sheng JY; Shi HJ
Cardiol J; 2019; 26(3):283-291. PubMed ID: 29611172
[TBL] [Abstract][Full Text] [Related]
6. First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
Sedaghat A; Sinning JM; Paul K; Kirfel G; Nickenig G; Werner N
Clin Res Cardiol; 2013 Jun; 102(6):413-25. PubMed ID: 23397592
[TBL] [Abstract][Full Text] [Related]
7. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
[TBL] [Abstract][Full Text] [Related]
8. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.
Larsen K; Cheng C; Tempel D; Parker S; Yazdani S; den Dekker WK; Houtgraaf JH; de Jong R; Swager-ten Hoor S; Ligtenberg E; Hanson SR; Rowland S; Kolodgie F; Serruys PW; Virmani R; Duckers HJ
Eur Heart J; 2012 Jan; 33(1):120-8. PubMed ID: 21733913
[TBL] [Abstract][Full Text] [Related]
9. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury.
Wu X; Yin T; Tian J; Tang C; Huang J; Zhao Y; Zhang X; Deng X; Fan Y; Yu D; Wang G
Regen Biomater; 2015 Jun; 2(2):87-96. PubMed ID: 26813006
[TBL] [Abstract][Full Text] [Related]
10. Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.
Lan H; Wang Y; Yin T; Wang Y; Liu W; Zhang X; Yu Q; Wang Z; Wang G
J Biomed Mater Res B Appl Biomater; 2016 Aug; 104(6):1237-47. PubMed ID: 26059710
[TBL] [Abstract][Full Text] [Related]
11. Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis.
Li J; Zhang Q; Li D; An Y; Kutryk MB
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):322-9. PubMed ID: 25412893
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of stents coated with antibody against CD105 on preventing restenosis and thrombosis in minipigs].
Cui S; Lü SZ; Chen YD; He GX; Yan HB; Meng LJ; Liu H; Song XT; Jin ZN; Ge CJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):648-51. PubMed ID: 21055292
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model.
Takabatake S; Hayashi K; Nakanishi C; Hao H; Sakata K; Kawashiri MA; Matsuda T; Yamagishi M
J Interv Cardiol; 2014 Feb; 27(1):63-72. PubMed ID: 24383571
[TBL] [Abstract][Full Text] [Related]
14. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis.
Lev EI; Leshem-Lev D; Mager A; Vaknin-Assa H; Harel N; Zimra Y; Bental T; Greenberg G; Dvir D; Solodky A; Assali A; Battler A; Kornowski R
Eur Heart J; 2010 Nov; 31(21):2625-32. PubMed ID: 20543191
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stent.
Yazdani SK; Kolodgie FD; Virmani R
Minerva Cardioangiol; 2012 Feb; 60(1):11-21. PubMed ID: 22322570
[TBL] [Abstract][Full Text] [Related]
17. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis.
George J; Herz I; Goldstein E; Abashidze S; Deutch V; Finkelstein A; Michowitz Y; Miller H; Keren G
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):e57-60. PubMed ID: 14615392
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of the heparin-coated stent on restenosis in the porcine model.
Ahn YK; Jeong MH; Kim JW; Kim SH; Cho JH; Cho JG; Park CS; Juhng SW; Park JC; Kang JC
Catheter Cardiovasc Interv; 1999 Nov; 48(3):324-30. PubMed ID: 10525239
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cell capture stent: safety and effectiveness.
Sethi R; Lee CH
J Interv Cardiol; 2012 Oct; 25(5):493-500. PubMed ID: 22612275
[TBL] [Abstract][Full Text] [Related]
20. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
